Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer

John’s Story: ‘I Am More Than MS’ 
September 13, 2017
Hepatitis C Epidemic Threatens Alaska’s Opioid Addicts
September 13, 2017
Show all

Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer

Reducing inflammation can also reduce the risk of heart disease and lung cancer.

A drug that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.

Researchers outside the study say the findings represent a major milestone — proof of a biologic concept that opens the door to new ways of treating and preventing cardiovascular disease in people who are still at risk despite standard therapies.

“This is fantastic,” said Dr. David J. Maron, the director of preventive cardiology at Stanford University School of Medicine. “The green light just went on for full-fledged investigation and development of effective and cost-effective new therapies.”

Read full article: Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer – The New York Times

Read Full Article: Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer – The New York Times

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.